X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Procter & Gamble Health with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ELDER PHARMA - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH ELDER PHARMA PROCTER & GAMBLE HEALTH/
ELDER PHARMA
 
P/E (TTM) x 51.4 -0.2 - View Chart
P/BV x 4.6 0.1 4,605.7% View Chart
Dividend Yield % 10.2 0.0 -  

Financials

 PROCTER & GAMBLE HEALTH   ELDER PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
ELDER PHARMA
Jun-14
PROCTER & GAMBLE HEALTH/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs3,549380 933.9%   
Low Rs1,301188 692.2%   
Sales per share (Unadj.) Rs511.4491.2 104.1%  
Earnings per share (Unadj.) Rs61.3-3.2 -1,926.4%  
Cash flow per share (Unadj.) Rs74.014.4 513.7%  
Dividends per share (Unadj.) Rs440.000-  
Dividend yield (eoy) %18.10-  
Book value per share (Unadj.) Rs927.8376.5 246.4%  
Shares outstanding (eoy) m16.6020.54 80.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.70.6 820.1%   
Avg P/E ratio x39.6-89.3 -44.3%  
P/CF ratio (eoy) x32.819.7 166.2%  
Price / Book Value ratio x2.60.8 346.5%  
Dividend payout %717.90-   
Avg Mkt Cap Rs m40,2575,833 690.1%   
No. of employees `0001.1NA-   
Total wages/salary Rs m1,3132,179 60.2%   
Avg. sales/employee Rs Th7,486.7NM-  
Avg. wages/employee Rs Th1,157.6NM-  
Avg. net profit/employee Rs Th897.2NM-  
INCOME DATA
Net Sales Rs m8,49010,089 84.1%  
Other income Rs m244257 95.1%   
Total revenues Rs m8,73410,346 84.4%   
Gross profit Rs m1,482-792 -187.1%  
Depreciation Rs m211361 58.5%   
Interest Rs m02,756 0.0%   
Profit before tax Rs m1,514-3,653 -41.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m663,713 1.8%   
Tax Rs m563125 449.5%   
Profit after tax Rs m1,017-65 -1,556.8%  
Gross profit margin %17.5-7.8 -222.3%  
Effective tax rate %37.1-3.4 -1,084.2%   
Net profit margin %12.0-0.6 -1,850.1%  
BALANCE SHEET DATA
Current assets Rs m15,3439,240 166.1%   
Current liabilities Rs m1,9609,998 19.6%   
Net working cap to sales %157.6-7.5 -2,099.0%  
Current ratio x7.80.9 846.9%  
Inventory Days Days4946 105.2%  
Debtors Days Days2860 47.5%  
Net fixed assets Rs m1,20910,124 11.9%   
Share capital Rs m166206 80.7%   
"Free" reserves Rs m15,2355,582 272.9%   
Net worth Rs m15,4017,734 199.1%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m17,59522,882 76.9%  
Interest coverage xNM-0.3-  
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.50.4 109.4%   
Return on assets %5.811.8 49.2%  
Return on equity %6.6-0.8 -781.8%  
Return on capital %10.322.3 46.0%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m1,636307 533.7%   
Fx outflow Rs m4,368125 3,486.1%   
Net fx Rs m-2,732181 -1,506.8%   
CASH FLOW
From Operations Rs m-1,30411,754 -11.1%  
From Investments Rs m12,697-561 -2,265.3%  
From Financial Activity Rs m-301-6,762 4.4%  
Net Cashflow Rs m11,0934,432 250.3%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 7.5 242.7%  
FIIs % 1.0 16.8 6.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 36.1 80.6%  
Shareholders   28,591 16,479 173.5%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DISHMAN PHARMA  WOCKHARDT  GSK PHARMA  ALEMBIC LTD  DR. REDDYS LAB  

Compare PROCTER & GAMBLE HEALTH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Witness Selling, Passenger Vehicles Sales Data, and Top Cues in Focus Today(Pre-Open)

India share markets witnessed selling pressure yesterday and ended their session deep in the red. At the closing bell yesterday, the BSE Sensex stood lower by 267 points (down 0.7%).

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Super investor Pulak Prasad is Buying Stocks Big Time...and You Should Too(The 5 Minute Wrapup)

Aug 9, 2019

Here's why the relentless correction in the Indian stock markets has not unnerved the big investors.

Interest Rates Are Low. Buy Solid Dividend Stocks Instead(The 5 Minute Wrapup)

Aug 13, 2019

The dividends paid by these stocks are helpful when interest rates are falling.

Smallcaps that Will Outperform in the Market Rebound(Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

Qatar is Rearing Cows...this is Good News for India

Aug 9, 2019

Qatar has turned around after the Saudi embargo. This is good news for India.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Aug 21, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 5-YR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS